Journal article
Cost-effectiveness of professional-mode flash glucose monitoring in general practice among adults with type 2 diabetes: Evidence from the GP-OSMOTIC trial
X Hua, M Catchpool, P Clarke, I Blackberry, J Chiang, E Holmes-Truscott, A Jenkins, K Khunti, D O'Neal, J Speight, J Furler, JA Manski-Nankervis, K Dalziel, J Best, D Liew, M Kennedy, R Audehm, S Thuraisingam, K De La Rue, L Ginnivan Show all
Diabetic Medicine | Published : 2022
DOI: 10.1111/dme.14747
Abstract
Aim: To assess the cost-effectiveness of professional-mode flash glucose monitoring in adults with type 2 diabetes in general practice compared with usual clinical care. Methods: An economic evaluation was conducted as a component of the GP-OSMOTIC trial, a pragmatic multicentre 12-month randomised controlled trial enrolling 299 adults with type 2 diabetes in Victoria, Australia. The economic evaluation was conducted from an Australian healthcare sector perspective with a lifetime horizon. Health-related quality of life (EQ-5D) and total healthcare costs were compared between the intervention and the usual care group within the trial period. The 'UKPDS Outcomes Model 2' was used to simulate ..
View full abstractGrants
Awarded by AstraZeneca
Funding Acknowledgements
Katie de la Rue, Louise Ginnivan, Kylie Crisp, Rebecca Hannam and Emily Knights assisted with running the clinical study and data collection. Katie de la Rue facilitated the process for linkage of the trial to health services data. Rita McMorrow assisted with analysis of Medicare data. KK is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM) and the NIHR Leicester Biomedical Research Centre (BRC). JS and EHT are supported by the core funding to the Australian Centre for Behavioural Research in Diabetes, provided by the collaboration between Diabetes Victoria and Deakin University.